MIRM
HealthcareMirum Pharmaceuticals, Inc.
$90.07+0.29 (+0.32%)
Prev Close
$89.78
Open
$90.13
High
$92.72
Low
$89.74
Volume
357.8K
Market Cap
$4.37B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Mirum Pharmaceuticals, Inc. (MIRM) has been dominated by selling, with 2 insider purchases totaling $9.02M and 32 insider sales totaling $28.44M. The most recent insider transaction was by Ramasastry Saira (Director), who sold $204.2K worth of shares on Feb 13, 2026. Mirum Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.37B.
Buys (12M)
2
$9.02M
Sells (12M)
32
$28.44M
Net Activity
Net Seller
$19.42M
Active Insiders
10
last 12 mo
MIRM Price Chart
MIRM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026↗ | Ramasastry Saira | Director | Sell | 2,000 | $102.09 | $204.2K | 0 |
| Feb 3, 2026↗ | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 968 | $103.30 | $100.0K | 4,503 |
| Feb 3, 2026↗ | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 9,108 | $103.30 | $940.9K | 160,294 |
| Feb 3, 2026↗ | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,631 | $103.30 | $271.8K | 20,655 |
| Jan 27, 2026↗ | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,053 | $96.19 | $101.3K | 43,741 |
| Jan 27, 2026↗ | Heron Patrick J | director | Buy | 131,425 | $68.48 | $9.00M | 459,010 |
| Jan 27, 2026↗ | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 842 | $96.19 | $81.0K | 3,700 |
| Jan 27, 2026↗ | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 6,831 | $96.19 | $657.1K | 169,402 |
| Jan 27, 2026↗ | Radovich Peter | officer: PRESIDENT AND COO | Sell | 3,143 | $96.19 | $302.3K | 23,286 |
| Jan 23, 2026↗ | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,421 | $93.33 | $132.6K | 42,127 |
| Jan 23, 2026↗ | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 926 | $93.33 | $86.4K | 3,042 |
| Jan 23, 2026↗ | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $93.33 | $662.4K | 163,733 |
| Jan 23, 2026↗ | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 1,822 | $93.33 | $170.0K | 12,817 |
| Jan 23, 2026↗ | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,382 | $93.33 | $222.3K | 20,679 |
| Jan 21, 2026↗ | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 6,911 | $90.27 | $623.9K | 11,305 |
| Jan 16, 2026↗ | Ramasastry Saira | director | Sell | 2,000 | $90.99 | $182.0K | 0 |
| Dec 23, 2025↗ | GREY MICHAEL G | Sell | 50,000 | $78.00 | $3.90M | 0 | |
| Dec 23, 2025↗ | Ramasastry Saira | Sell | 5,000 | $80.00 | $400.0K | 0 | |
| Dec 19, 2025↗ | Ramasastry Saira | Sell | 2,000 | $69.73 | $139.5K | 1,000 | |
| Dec 2, 2025↗ | GREY MICHAEL G | Sell | 50,000 | $74.00 | $3.70M | 0 | |
| Nov 25, 2025↗ | GREY MICHAEL G | Sell | 50,000 | $70.00 | $3.50M | 0 | |
| Sep 12, 2025↗ | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | 9,578 | $76.01 | $728.0K | 39,945 |
| Sep 12, 2025↗ | Brege Laura | Sell | 17,000 | $74.40 | $1.26M | 17,194 | |
| Aug 12, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $62.00 | $2.48M | 138,641 |
| Aug 8, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 10,000 | $58.00 | $580.0K | 2,426 |
| Aug 8, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $55.25 | $2.21M | 138,641 |
| Jul 3, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,041 | $48.63 | $50.6K | 2,903 |
| Jun 13, 2025↗ | Fairey William | Sell | 3,203 | $48.42 | $155.1K | 2,500 | |
| Jun 4, 2025↗ | Ramasastry Saira | Sell | 8,203 | $46.06 | $377.8K | 0 | |
| Mar 19, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,415 | $44.45 | $107.3K | 2,426 |
| Mar 18, 2025↗ | Heron Patrick J | Buy | 549 | $44.11 | $24.2K | 168,672 | |
| Mar 18, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 57,606 | $44.35 | $2.55M | 9,436 |
| Mar 18, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 27,279 | $44.21 | $1.21M | 138,641 |
| Mar 18, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 7,879 | $44.21 | $348.4K | 18,672 |
| Mar 12, 2025↗ | Heron Patrick J | Buy | 2,298 | $43.31 | $99.5K | 168,123 | |
| Mar 10, 2025↗ | Heron Patrick J | Buy | 1,915 | $43.69 | $83.7K | 165,825 | |
| Mar 6, 2025↗ | Heron Patrick J | Buy | 1,602 | $45.40 | $72.7K | 163,910 | |
| Mar 5, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 14,850 | $45.58 | $676.9K | 13,280 |
| Mar 4, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $46.91 | $1.88M | 136,528 |
| Feb 4, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,064 | $48.22 | $51.3K | 4,232 |
| Feb 4, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 9,102 | $48.22 | $438.9K | 115,920 |
| Feb 4, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 2,627 | $48.22 | $126.7K | 26,961 |
| Jan 27, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 902 | $47.92 | $43.2K | 3,524 |
| Jan 27, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 6,837 | $47.92 | $327.7K | 125,022 |
| Jan 27, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 3,177 | $47.92 | $152.3K | 29,588 |
| Jan 21, 2025↗ | Quan Joanne | CHIEF MEDICAL OFFICER | Sell | 6,969 | $45.86 | $319.6K | 5,649 |
| Jan 8, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 750 | $42.82 | $32.1K | 2,926 |
| Jan 8, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 7,489 | $42.82 | $320.6K | 119,359 |
| Jan 8, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 1,998 | $42.82 | $85.5K | 27,015 |
| Nov 15, 2024↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,500 | $47.10 | $117.8K | 2,426 |
Showing 1–50 of 99
1 / 2
MIRM Insider Buying Activity
The following table shows recent insider purchases of Mirum Pharmaceuticals, Inc. (MIRM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026↗ | Heron Patrick J | director | Buy | 131,425 | $68.48 | $9.00M | 459,010 |
| Mar 18, 2025↗ | Heron Patrick J | Buy | 549 | $44.11 | $24.2K | 168,672 | |
| Mar 12, 2025↗ | Heron Patrick J | Buy | 2,298 | $43.31 | $99.5K | 168,123 | |
| Mar 10, 2025↗ | Heron Patrick J | Buy | 1,915 | $43.69 | $83.7K | 165,825 | |
| Mar 6, 2025↗ | Heron Patrick J | Buy | 1,602 | $45.40 | $72.7K | 163,910 |
MIRM Insider Selling Activity
The following table shows recent insider sales of Mirum Pharmaceuticals, Inc. (MIRM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026↗ | Ramasastry Saira | Director | Sell | 2,000 | $102.09 | $204.2K | 0 |
| Feb 3, 2026↗ | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 968 | $103.30 | $100.0K | 4,503 |
| Feb 3, 2026↗ | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 9,108 | $103.30 | $940.9K | 160,294 |
| Feb 3, 2026↗ | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,631 | $103.30 | $271.8K | 20,655 |
| Jan 27, 2026↗ | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,053 | $96.19 | $101.3K | 43,741 |
| Jan 27, 2026↗ | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 842 | $96.19 | $81.0K | 3,700 |
| Jan 27, 2026↗ | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 6,831 | $96.19 | $657.1K | 169,402 |
| Jan 27, 2026↗ | Radovich Peter | officer: PRESIDENT AND COO | Sell | 3,143 | $96.19 | $302.3K | 23,286 |
| Jan 23, 2026↗ | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,421 | $93.33 | $132.6K | 42,127 |
| Jan 23, 2026↗ | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 926 | $93.33 | $86.4K | 3,042 |
| Jan 23, 2026↗ | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $93.33 | $662.4K | 163,733 |
| Jan 23, 2026↗ | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 1,822 | $93.33 | $170.0K | 12,817 |
| Jan 23, 2026↗ | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,382 | $93.33 | $222.3K | 20,679 |
| Jan 21, 2026↗ | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 6,911 | $90.27 | $623.9K | 11,305 |
| Jan 16, 2026↗ | Ramasastry Saira | director | Sell | 2,000 | $90.99 | $182.0K | 0 |
| Dec 23, 2025↗ | GREY MICHAEL G | Sell | 50,000 | $78.00 | $3.90M | 0 | |
| Dec 23, 2025↗ | Ramasastry Saira | Sell | 5,000 | $80.00 | $400.0K | 0 | |
| Dec 19, 2025↗ | Ramasastry Saira | Sell | 2,000 | $69.73 | $139.5K | 1,000 | |
| Dec 2, 2025↗ | GREY MICHAEL G | Sell | 50,000 | $74.00 | $3.70M | 0 | |
| Nov 25, 2025↗ | GREY MICHAEL G | Sell | 50,000 | $70.00 | $3.50M | 0 | |
| Sep 12, 2025↗ | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | 9,578 | $76.01 | $728.0K | 39,945 |
| Sep 12, 2025↗ | Brege Laura | Sell | 17,000 | $74.40 | $1.26M | 17,194 | |
| Aug 12, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $62.00 | $2.48M | 138,641 |
| Aug 8, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 10,000 | $58.00 | $580.0K | 2,426 |
| Aug 8, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $55.25 | $2.21M | 138,641 |
| Jul 3, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,041 | $48.63 | $50.6K | 2,903 |
| Jun 13, 2025↗ | Fairey William | Sell | 3,203 | $48.42 | $155.1K | 2,500 | |
| Jun 4, 2025↗ | Ramasastry Saira | Sell | 8,203 | $46.06 | $377.8K | 0 | |
| Mar 19, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,415 | $44.45 | $107.3K | 2,426 |
| Mar 18, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 57,606 | $44.35 | $2.55M | 9,436 |
| Mar 18, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 27,279 | $44.21 | $1.21M | 138,641 |
| Mar 18, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 7,879 | $44.21 | $348.4K | 18,672 |
| Mar 5, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 14,850 | $45.58 | $676.9K | 13,280 |
| Mar 4, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $46.91 | $1.88M | 136,528 |
| Feb 4, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,064 | $48.22 | $51.3K | 4,232 |
| Feb 4, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 9,102 | $48.22 | $438.9K | 115,920 |
| Feb 4, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 2,627 | $48.22 | $126.7K | 26,961 |
| Jan 27, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 902 | $47.92 | $43.2K | 3,524 |
| Jan 27, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 6,837 | $47.92 | $327.7K | 125,022 |
| Jan 27, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 3,177 | $47.92 | $152.3K | 29,588 |
| Jan 21, 2025↗ | Quan Joanne | CHIEF MEDICAL OFFICER | Sell | 6,969 | $45.86 | $319.6K | 5,649 |
| Jan 8, 2025↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 750 | $42.82 | $32.1K | 2,926 |
| Jan 8, 2025↗ | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 7,489 | $42.82 | $320.6K | 119,359 |
| Jan 8, 2025↗ | Radovich Peter | PRESIDENT AND COO | Sell | 1,998 | $42.82 | $85.5K | 27,015 |
| Nov 15, 2024↗ | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,500 | $47.10 | $117.8K | 2,426 |
MIRM Insiders
Similar Stocks to MIRM
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B